Feb 25 (Reuters) - Next Science Ltd NXS.AX:
NEXT SCIENCE RECEIVES FDA WARNING LETTER
WARNING LETTER RELATES TO FDA'S INSPECTION OF CO'S JACKSONVILLE, FLORIDA FACILITY DURING AUG & SEPT 2024
UNDERTAKEN CORRECTIVE ACTIONS TO ADDRESS MATTERS RAISED BY FDA, INCLUDING REVISING PRODUCT DESCRIPTIONS ON CO'S WEBSITE
Further company coverage: NXS.AX
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.